Log in to save to my catalogue

Indirect estimation of the prevalence of spinal muscular atrophy Type I, II, and III in the United S...

Indirect estimation of the prevalence of spinal muscular atrophy Type I, II, and III in the United S...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_61ca2b24b4a14982a5b8970d8e5137bf

Indirect estimation of the prevalence of spinal muscular atrophy Type I, II, and III in the United States

About this item

Full title

Indirect estimation of the prevalence of spinal muscular atrophy Type I, II, and III in the United States

Publisher

England: BioMed Central Ltd

Journal title

Orphanet journal of rare diseases, 2017-11, Vol.12 (1), p.175-175, Article 175

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Spinal muscular atrophy (SMA) is a progressive, devastating disease and a leading inherited cause of infant mortality. The limited population-based literature is confined to small regional studies. Estimates of prevalence are needed to characterize the burden of SMA and to understand trends in prevalence by disease type as new treatments become ava...

Alternative Titles

Full title

Indirect estimation of the prevalence of spinal muscular atrophy Type I, II, and III in the United States

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_61ca2b24b4a14982a5b8970d8e5137bf

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_61ca2b24b4a14982a5b8970d8e5137bf

Other Identifiers

ISSN

1750-1172

E-ISSN

1750-1172

DOI

10.1186/s13023-017-0724-z

How to access this item